002287.SZ
奇正藏药
SZSE · Healthcare · C 制造业 · CN
CNY 19.73
−0.65%Year over year
Reported trailing growth
- Revenue
- +1.8%
- EBITDA
- —
- EBIT
- +21.2%
- EPS
- +17.0%
- Free cash flow
- -71.4%
- Operating cash flow
- -65.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +5.7%
- EBITDA
- +14.6%
- EBIT
- +13.8%
- Net income
- +11.1%
- EPS
- +10.2%
- Free cash flow
- +251.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026